Advocacy

“NCBIO has consistently provided North Carolina's public leaders with timely, accurate, industry-based information concerning the needs of North Carolina's rapidly growing biotechnology and other life-science related businesses. We are now poised to do even more for our state's fast-growing life-science sector.” —Dr. Charles E. Hamner,
NCBIO President Emeritus

Highlights

Capital Access

Capital is a critical need of all bioscience companies.  NCBIO works constantly to expand public investments in bioscience companies and life-science venture funds, loans for bioscience businesses, and tax incentives for investments and research.

Workforce Training and Education

Bioscience companies require highly educated scientists, laboratory technicians, manufacturing workers and other trained employees.  North Carolina is spending more than $60 million on a new Biomanufacturing and Pharmaceutical Training Consortium (BPTC) proposed by NCBIO.  NCBIO is coordinating industry support and input for the Consortium.

University Research and Technology Transfer 

Basic research is a wellspring of bioscience technology and business growth.  NCBIO works to expand state funding for life science research grants and to protect and enhance university access to federal research dollars.

Tax and Regulatory Issues.  Bioscience companies grow best in a nurturing business climate.  NCBIO supports favorable tax treatment for biomanufacturing research and manufacturing expansions, government support for bioscience-related infrastructure. The Organization also aggressively opposes initiatives that depress the price of drugs and other health care products and seeks to assure that any new regulation of bioscience technologies is both necessary and rationale.